Detailed characterization (IC50, IC90) of the antiviral activity of each identified inhibitor against MA SARS-CoV-2 and Omicron

Task 19 To confirm the efficacy of developed antivirals against cellfree and cellcell infection of a mouse adapted SARSCoV2 strain and VOCs month 2430Objectives To establish an infection model with a mouse adapted SARSCoV2 strain and to evaluate the antiviral activity of most promising SARSCoV2 inhibitors developed in the consortium